Abstract：
BACKGROUND: Policies, protocols and processes within organisations can facilitate or hinder guideline adoption. There is limited knowledge on the strategies used by organisations to disseminate and implement evidence-based deprescribing guidelines or their impact.
METHODS: We aimed to develop an online survey targeting key organisations involved in deprescribing guideline endorsement, dissemination, modification or translation internationally. Survey questions were drafted, mirroring the six components of the reach, effectiveness, adoption, implementation and maintenance (RE-AIM) framework. Content validation was undertaken and established by a panel of clinicians, researchers and implementation experts.
RESULTS: A 52-item survey underwent two rounds of content validation. The minimum threshold (I-CVI > 0.78) for relevance and importance was met for 39 items (75%) in the first round and 44 of 48 items (92%) in the second round. The expert panel concluded that the adoption, implementation and effectiveness survey sections were largely relevant and important to this topic, whereas the reach and maintenance sections were harder to understand and may be less pertinent to the research question.
CONCLUSIONS: A 44-item survey investigating dissemination and implementation strategies for deprescribing guidelines has been developed and its content validated. Widespread survey distribution may identify effective strategies and inform dissemination and implementation planning for newly developed guidelines.
METHODS: We aimed to develop an online survey targeting key organisations involved in deprescribing guideline endorsement, dissemination, modification or translation internationally. Survey questions were drafted, mirroring the six components of the reach, effectiveness, adoption, implementation and maintenance (RE-AIM) framework. Content validation was undertaken and established by a panel of clinicians, researchers and implementation experts.
RESULTS: A 52-item survey underwent two rounds of content validation. The minimum threshold (I-CVI > 0.78) for relevance and importance was met for 39 items (75%) in the first round and 44 of 48 items (92%) in the second round. The expert panel concluded that the adoption, implementation and effectiveness survey sections were largely relevant and important to this topic, whereas the reach and maintenance sections were harder to understand and may be less pertinent to the research question.
CONCLUSIONS: A 44-item survey investigating dissemination and implementation strategies for deprescribing guidelines has been developed and its content validated. Widespread survey distribution may identify effective strategies and inform dissemination and implementation planning for newly developed guidelines.
摘要：
背景：政策，协议,组织内的过程可以促进或阻碍指南的采用。对组织传播和实施基于证据的非处方指南所使用的策略的知识有限，或其影响。
方法：我们的目标是开发一个在线调查，针对涉及取消处方指南认可的关键组织，传播,修改,或国际翻译。起草了调查问题，镜像到达的六个组件，有效性,收养,实施和维护(RE-AIM)框架。内容验证由一组临床医生进行并建立，研究和实施专家。
结果：一项52项调查进行了两轮内容验证。相关性和重要性的最低阈值（I-CVI>0.78）在第一轮中达到39个项目（75％），在第二轮中达到48个项目中的44个项目（92％）。专家小组的结论是，收养，实施和有效性调查部分在很大程度上与这一主题相关和重要，而到达和维护部分更难理解，可能与研究问题不太相关。
结论：已经制定了一项44项调查，调查了无处方指南的传播和实施策略，并对内容进行了验证。广泛的调查分发可以确定有效的战略，并为新制定的准则的传播和实施规划提供信息。
方法：我们的目标是开发一个在线调查，针对涉及取消处方指南认可的关键组织，传播,修改,或国际翻译。起草了调查问题，镜像到达的六个组件，有效性,收养,实施和维护(RE-AIM)框架。内容验证由一组临床医生进行并建立，研究和实施专家。
结果：一项52项调查进行了两轮内容验证。相关性和重要性的最低阈值（I-CVI>0.78）在第一轮中达到39个项目（75％），在第二轮中达到48个项目中的44个项目（92％）。专家小组的结论是，收养，实施和有效性调查部分在很大程度上与这一主题相关和重要，而到达和维护部分更难理解，可能与研究问题不太相关。
结论：已经制定了一项44项调查，调查了无处方指南的传播和实施策略，并对内容进行了验证。广泛的调查分发可以确定有效的战略，并为新制定的准则的传播和实施规划提供信息。
